Overview

• Valisure, an independent laboratory, found high levels of benzene, a known carcinogen, in popular acne treatments containing benzoyl peroxide from brands like Proactiv, Clearasil, Clinique, and others.
• The FDA has been petitioned by Valisure to recall the affected products and revise industry guidance due to the potential health risks posed by benzene exposure.
• Benzene formation in these products is attributed to the decomposition of benzoyl peroxide, especially under high temperatures, posing risks of both contact and inhalation exposure.
• Some manufacturers, including Reckitt (Clearasil's parent company) and Estée Lauder (Clinique's parent), have responded by asserting the safety of their products when used as directed.
• This discovery follows previous findings of benzene in other consumer products like sunscreens, hand sanitizers, and dry shampoos, leading to recalls and increased scrutiny on product safety.